Q4 2024 Earnings Call Transcript January 29, 2025 Stifel Financial Corp. beats earnings expectations. Reported EPS is $2.23, ...

Stifel lowered the firm’s price target on Danaher (DHR) to $260 from $265 and keeps a Hold rating on the shares. Danaher ...

Stifel analyst David Grossman raised the firm’s price target on IBM (IBM) to $271 from $246 and keeps a Buy rating on the shares. The stock was up 8%-9% in after-market trading, which likely reflects ...

While total segment revenue declined 6.6% year-over-year due to weak truckload (TL) demand and lower rates, gross margins ...

Fintel reports that on January 30, 2025, Stifel upgraded their outlook for Edwards Lifesciences (NYSE:EW) from Hold to Buy.

The firm’s CEO cited a “very competitive” recruiting market in 2024, but forecasts a better 2025 as longer-term efforts pay ...

Stifel Nicolaus analyst Ian Gillies maintained a Buy rating on Badger Infrastructure Solutions (BADFF – Research Report) today and set a price ...

In a report released today, Cole McGill from Stifel Nicolaus maintained a Buy rating on Hudbay Minerals (HBM – Research Report), with a price ...

Edwards Lifesciences (NYSE: EW) stock rises after Stifel upgrades to Buy, citing potential for TAVR growth acceleration in 2025. Read more here.

The natural beauty of West Virginia will be celebrated both musically and visually in the Wheeling Symphony Orchestra’s upcoming performance, “Nature. Beauty.” Set for 2 p.m., Feb. 8, at the Capitol ...